BE895991A - Nouvelles modifications cristallines, procede pour leur production, et preparations pharmaceutiques les contenant - Google Patents

Nouvelles modifications cristallines, procede pour leur production, et preparations pharmaceutiques les contenant

Info

Publication number
BE895991A
BE895991A BE0/210184A BE210184A BE895991A BE 895991 A BE895991 A BE 895991A BE 0/210184 A BE0/210184 A BE 0/210184A BE 210184 A BE210184 A BE 210184A BE 895991 A BE895991 A BE 895991A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparations
production
preparations containing
novel crystalline
crystalline modifications
Prior art date
Application number
BE0/210184A
Other languages
English (en)
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of BE895991A publication Critical patent/BE895991A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BE0/210184A 1982-02-24 1983-02-23 Nouvelles modifications cristallines, procede pour leur production, et preparations pharmaceutiques les contenant BE895991A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8205453 1982-02-24

Publications (1)

Publication Number Publication Date
BE895991A true BE895991A (fr) 1983-08-23

Family

ID=10528576

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210184A BE895991A (fr) 1982-02-24 1983-02-23 Nouvelles modifications cristallines, procede pour leur production, et preparations pharmaceutiques les contenant

Country Status (30)

Country Link
US (1) US4515804A (fr)
EP (1) EP0087164B1 (fr)
JP (1) JPS58185578A (fr)
KR (1) KR900006557B1 (fr)
AT (2) ATE27456T1 (fr)
AU (1) AU566685B2 (fr)
BE (1) BE895991A (fr)
CA (1) CA1212381A (fr)
CH (1) CH654004A5 (fr)
DD (1) DD208613A5 (fr)
DE (2) DE3371785D1 (fr)
DK (1) DK80983A (fr)
ES (1) ES8504977A1 (fr)
FI (1) FI76330C (fr)
FR (1) FR2521995A1 (fr)
GB (1) GB2115409B (fr)
GR (1) GR77918B (fr)
HU (1) HU194854B (fr)
IL (1) IL67969A (fr)
IN (1) IN157218B (fr)
IT (1) IT1197582B (fr)
LU (1) LU84657A1 (fr)
NL (1) NL8300600A (fr)
NO (1) NO830629L (fr)
NZ (1) NZ203369A (fr)
PH (1) PH20689A (fr)
PL (1) PL141809B1 (fr)
PT (1) PT76279B (fr)
SE (1) SE8300974L (fr)
ZA (1) ZA831216B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
WO1987006128A1 (fr) * 1986-04-07 1987-10-22 Clemetson Ab Charles Acide ascorbique revetu de catechine, et procede d'obtention
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
WO1994022322A1 (fr) * 1993-04-01 1994-10-13 Kalamazoo Holdings, Inc. Antioxydants solides microcristallins a base de catechines de the vert, pour lipides
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
JP4723239B2 (ja) 2002-04-30 2011-07-13 ユニジェン・インコーポレーテッド 治療剤としての遊離−b−環フラボノイド類とフラバン類との混合物の製剤
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
AU2004228021B2 (en) 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
CN103833713B (zh) * 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iii型、其制法和其药物组合物与用途
US11974982B2 (en) 2020-04-03 2024-05-07 The Board Of Trustees Of The University Of Illinois Stimulus-responsive antioxidant crystals and method for their preparation

Also Published As

Publication number Publication date
PL240734A1 (en) 1984-11-08
NZ203369A (en) 1986-03-14
ATA62083A (de) 1986-10-15
SE8300974D0 (sv) 1983-02-22
CH654004A5 (de) 1986-01-31
JPH032154B2 (fr) 1991-01-14
FI830571A0 (fi) 1983-02-21
AU566685B2 (en) 1987-10-29
EP0087164B1 (fr) 1987-05-27
PL141809B1 (en) 1987-08-31
ZA831216B (en) 1985-03-27
GR77918B (fr) 1984-09-25
NO830629L (no) 1983-08-25
FR2521995B1 (fr) 1984-09-07
DE3371785D1 (en) 1987-07-02
GB2115409B (en) 1985-08-07
ES519982A0 (es) 1985-04-16
GB8302562D0 (en) 1983-03-02
IN157218B (fr) 1986-02-15
GB2115409A (en) 1983-09-07
FI76330C (fi) 1988-10-10
KR900006557B1 (ko) 1990-09-13
PT76279B (en) 1986-03-19
CA1212381A (fr) 1986-10-07
DK80983D0 (da) 1983-02-23
AT383123B (de) 1987-05-25
FI830571L (fi) 1983-08-25
EP0087164A1 (fr) 1983-08-31
JPS58185578A (ja) 1983-10-29
KR840003625A (ko) 1984-09-15
ATE27456T1 (de) 1987-06-15
IL67969A0 (en) 1983-06-15
SE8300974L (sv) 1983-08-25
DD208613A5 (de) 1984-04-04
ES8504977A1 (es) 1985-04-16
FR2521995A1 (fr) 1983-08-26
DE3306092A1 (de) 1983-09-01
PH20689A (en) 1987-03-24
DK80983A (da) 1983-08-25
NL8300600A (nl) 1983-09-16
LU84657A1 (de) 1983-09-08
US4515804A (en) 1985-05-07
FI76330B (fi) 1988-06-30
IT8347760A0 (it) 1983-02-22
IT1197582B (it) 1988-12-06
AU1178583A (en) 1983-09-01
PT76279A (en) 1983-03-01
IL67969A (en) 1986-11-30
HU194854B (en) 1988-03-28

Similar Documents

Publication Publication Date Title
BE895991A (fr) Nouvelles modifications cristallines, procede pour leur production, et preparations pharmaceutiques les contenant
NO892762D0 (no) Fremgangsmaate for fremstilling av nye difosfonsyrederivater.
RO89714A (fr) Procede de preparation des derives de 5-methylthiopyrimidine
FR2557108B1 (fr) 5-pyrimidinecarboxamide ou thiocarboxamide, composition pharmaceutique pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs le contenant, procede de production de 5-pyrimidinecarboxamide ou thiocarboxamide et procede pour induire la regression de la leucemie et l'inhibition de la croissance des tumeurs en l'utilisant
BE887324A (fr) Procede de preparation de la relaxine humaine
RO85384A (fr) Procede de preparation des derives de la pyridine
FR2618779B1 (fr) Nouveau procede de preparation des 1,2,4-triazol-3-ones
FR2612188B1 (fr) 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-0,4-dithiines, compositions pharmaceutiques les contenant et procede pour le traitement de la leucemie et des tumeurs les utilisant
PT69327A (fr) Procede d'isomerisation des derives de la vinyl-3 piperidine
FR2534585B1 (fr) Procede de production d'alkylangelicines denuees de psoralens et alkylangelicines obtenues par ce procede
FR2310329A1 (fr) Procede de production de phenylcyclohexane au depart de dicyclohexylbenzenes
RO82035A (fr) Procede pour la preparation des derives 1-oxa-beta-lactamiques
FR2613716B1 (fr) Procede de preparation de 1-phenyl-3-carbalkyloxy-5-hydroxypyrazoles purs
FR2625497B1 (fr) Procede de preparation des hypochlorites organiques
FR2521164B1 (fr) Procede pour la production de kallikreine humaine
PT79027A (fr) Procede de preparation de compositions pharmaceutiques contenant de la quinine
RO92697A2 (fr) Procede pour la preparation des derives de coumarine
RO94549A2 (fr) Procede pour la preparation de la coumarine
FR2623497B1 (fr) Procede de preparation de perfluoroalcanecarboxamides
RO84648A2 (fr) Procede de preparation des phosphates organiques polyetho0yles
RO66960A2 (fr) Procede pour preparation d'une produit actif par les boues
FR2619379B1 (fr) Procede pour la o-alkylation de n-(hydroxy) aralkyl-phenylethanolamines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ZYMA S.A.

Effective date: 19890228